1. Home
  2. AOS vs PRAX Comparison

AOS vs PRAX Comparison

Compare AOS & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo A.O. Smith Corporation

AOS

A.O. Smith Corporation

HOLD

Current Price

$64.51

Market Cap

9.2B

Sector

Industrials

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$331.64

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AOS
PRAX
Founded
1874
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
9.6B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
AOS
PRAX
Price
$64.51
$331.64
Analyst Decision
Hold
Strong Buy
Analyst Count
9
15
Target Price
$75.44
$572.13
AVG Volume (30 Days)
1.3M
340.4K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
2.24%
N/A
EPS Growth
6.06
N/A
EPS
3.85
N/A
Revenue
$3,830,200,000.00
N/A
Revenue This Year
$4.51
N/A
Revenue Next Year
$3.80
$7,758.26
P/E Ratio
$16.70
N/A
Revenue Growth
0.32
N/A
52 Week Low
$62.14
$34.89
52 Week High
$81.87
$354.87

Technical Indicators

Market Signals
Indicator
AOS
PRAX
Relative Strength Index (RSI) 44.81 52.86
Support Level $62.94 $282.49
Resistance Level $67.48 $353.83
Average True Range (ATR) 1.61 17.80
MACD 0.19 0.80
Stochastic Oscillator 44.87 47.50

Price Performance

Historical Comparison
AOS
PRAX

About AOS A.O. Smith Corporation

A.O. Smith Corp manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments: North America (75% of sales) and the rest of the world (25% of sales). A.O. Smith is the manufacturer of water heaters in North America for the residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for the majority of North American sales and are distributed equally through wholesale and retail channels. The majority of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s. However, the firm announced a strategic review of its China operations.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: